Filing metadata

Accession number
0000950170-25-094576
Form type
Form 4
Filer
Damora Therapeutics, Inc.
CIK
CIK 1800315
Filed
Jul 08, 2025
Reporting period
Jul 03, 2025
Description
Insider transaction

Explore SEC Filings Hub